Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

60.0%

3 terminated/withdrawn out of 5 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03958357Completed

Post Market Clinical Follow-up Study Venezia

Role: collaborator

NCT04128852Not ApplicableWithdrawn

Post Marketing Clinical Follow up Study for MagnetOs Putty in Patients With Degenerative Disc Disease

Role: collaborator

NCT03801382Not ApplicableCompleted

Psychometric Properties of IntelliSpace Cognition

Role: collaborator

NCT03735940Not ApplicableTerminated

Clinical Evaluation Program of DeltaScan (ICU)

Role: collaborator

NCT03735927Not ApplicableTerminated

Clinical Evaluation Program of DeltaScan (Ward)

Role: collaborator

All 5 trials loaded